↓ Skip to main content

Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies

Overview of attention for article published in Frontiers in immunology, February 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
2 news outlets
twitter
19 X users
patent
2 patents

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies
Published in
Frontiers in immunology, February 2018
DOI 10.3389/fimmu.2018.00252
Pubmed ID
Authors

Richard Duggleby, Robert David Danby, J. Alejandro Madrigal, Aurore Saudemont

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 110 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 15%
Student > Ph. D. Student 10 9%
Student > Doctoral Student 10 9%
Student > Bachelor 9 8%
Other 9 8%
Other 23 21%
Unknown 33 30%
Readers by discipline Count As %
Immunology and Microbiology 22 20%
Medicine and Dentistry 20 18%
Biochemistry, Genetics and Molecular Biology 10 9%
Agricultural and Biological Sciences 6 5%
Unspecified 3 3%
Other 15 14%
Unknown 34 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2024.
All research outputs
#1,271,729
of 25,721,020 outputs
Outputs from Frontiers in immunology
#1,117
of 32,237 outputs
Outputs of similar age
#30,621
of 457,552 outputs
Outputs of similar age from Frontiers in immunology
#24
of 664 outputs
Altmetric has tracked 25,721,020 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,237 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 457,552 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 664 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.